
Darien Biodiscovery is a virtual Contract Research Organization (CRO) specializing in RNA-targeted drug discovery. They offer AI-driven computational services, including RNA-ligand interaction modeling, RNA structure prediction, and gigascale library design. Their key differentiators include deep RNA-centric expertise, massive computational power to screen over 10 billion compounds, and a zero-overhead model where clients retain full intellectual property. They leverage a proprietary technology stack combining physics-based simulations with AI/ML, including their DeepFoldRNA™ model for structure prediction and RiboAffinity scoring function for RNA-ligand interactions. Their services are designed to accelerate drug discovery for academic researchers, biotech innovators, and pharmaceutical partners, focusing on RNA targets like viral elements and lncRNAs, with a business model centered on providing results and expertise without requiring clients to manage infrastructure or software licenses.

Darien Biodiscovery is a virtual Contract Research Organization (CRO) specializing in RNA-targeted drug discovery. They offer AI-driven computational services, including RNA-ligand interaction modeling, RNA structure prediction, and gigascale library design. Their key differentiators include deep RNA-centric expertise, massive computational power to screen over 10 billion compounds, and a zero-overhead model where clients retain full intellectual property. They leverage a proprietary technology stack combining physics-based simulations with AI/ML, including their DeepFoldRNA™ model for structure prediction and RiboAffinity scoring function for RNA-ligand interactions. Their services are designed to accelerate drug discovery for academic researchers, biotech innovators, and pharmaceutical partners, focusing on RNA targets like viral elements and lncRNAs, with a business model centered on providing results and expertise without requiring clients to manage infrastructure or software licenses.